tradingkey.logo


tradingkey.logo


Accendra Health Ord Shs

ACH
2.155USD
+0.055+2.62%
āļ›āļīāļ” 03/30, 16:00ETāļĢāļēāļ„āļēāļĨāđˆāļēāļŠāđ‰āļē 15 āļ™āļēāļ—āļĩ
166.36MāļĄāļđāļĨāļ„āđˆāļēāļ•āļĨāļēāļ”
āļ‚āļēāļ”āļ—āļļāļ™P/E TTM


āļĢāļēāļĒāļĨāļ°āđ€āļ­āļĩāļĒāļ”āđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄāļ‚āļ­āļ‡ āļšāļĢāļīāļĐāļąāļ—

āļ‚āđ‰āļ­āļĄāļđāļĨ Accendra Health Ord Shs


āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™- -
āļŠāļ·āđˆāļ­āļšāļĢāļīāļĐāļąāļ—- -
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļ- -
āļ‹āļĩāļ­āļĩāđ‚āļ­- -
āļˆāļģāļ™āļ§āļ™āļžāļ™āļąāļāļ‡āļēāļ™- -
āļ›āļĢāļ°āđ€āļ āļ—āļāļēāļĢāļĢāļąāļāļĐāļēāļ„āļ§āļēāļĄāļ›āļĨāļ­āļ”āļ āļąāļĒ- -
āļŠāļīāđ‰āļ™āļ›āļĩāļ‡āļšāļ›āļĢāļ°āļĄāļēāļ“- -
āļ—āļĩāđˆāļ­āļĒāļđāđˆ- -
āđ€āļĄāļ·āļ­āļ‡- -
āļ•āļĨāļēāļ”āļŦāļĨāļąāļāļ—āļĢāļąāļžāļĒāđŒ- -
āļ›āļĢāļ°āđ€āļ—āļĻ- -
āļĢāļŦāļąāļŠāđ„āļ›āļĢāļĐāļ“āļĩāļĒāđŒ- -
āđ‚āļ—āļĢāļĻāļąāļžāļ—āđŒ- -
āđ€āļ§āđ‡āļšāđ„āļ‹āļ•āđŒ- -
āļŠāļąāļāļĨāļąāļāļĐāļ“āđŒāļĒāđˆāļ­āļ‚āļ­āļ‡āļŦāļļāđ‰āļ™- -
āļ§āļąāļ™āļ—āļĩāđˆāđ€āļŠāļ™āļ­āļ‚āļēāļĒāļ„āļĢāļąāđ‰āļ‡āđāļĢāļ- -
āļ‹āļĩāļ­āļĩāđ‚āļ­- -

āļœāļđāđ‰āļšāļĢāļīāļŦāļēāļĢāļšāļĢāļīāļĐāļąāļ—āļ‚āļ­āļ‡ Accendra Health Ord Shs


āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. Edward A. Pesicka
Mr. Edward A. Pesicka
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.15M
-3.06%
Mr. Perry A. Bernocchi
Mr. Perry A. Bernocchi
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
342.66K
+31.72%
Mr. Jonathan A. Leon
Mr. Jonathan A. Leon
Chief Financial Officer, Executive Vice President, Principal Accounting Officer
Chief Financial Officer, Executive Vice President, Principal Accounting Officer
303.59K
+28.02%
Mr. Robert J. (Bob) Henkel
Mr. Robert J. (Bob) Henkel
Independent Director
Independent Director
66.26K
+43.64%
Mr. Kenneth (Kenny) Gardner-Smith
Mr. Kenneth (Kenny) Gardner-Smith
Independent Director
Independent Director
54.92K
+52.65%
Lt. Gen. Gwendolyn M. Bingham
Lt. Gen. Gwendolyn M. Bingham
Independent Director
Independent Director
22.18K
--
Mr. Mark A. Beck
Mr. Mark A. Beck
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Stephen W. (Steve) Klemash
Mr. Stephen W. (Steve) Klemash
Independent Director
Independent Director
--
--
Ms. Rita F. Johnson-Mills
Ms. Rita F. Johnson-Mills
Independent Director
Independent Director
--
--
Ms. Teresa L. Kline
Ms. Teresa L. Kline
Independent Director
Independent Director
--
--
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
āļŠāļ·āđˆāļ­
āļŠāļ·āđˆāļ­/āļ•āļģāđāļŦāļ™āđˆāļ‡
āļ•āļģāđāļŦāļ™āđˆāļ‡
āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
Mr. Edward A. Pesicka
Mr. Edward A. Pesicka
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.15M
-3.06%
Mr. Perry A. Bernocchi
Mr. Perry A. Bernocchi
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
342.66K
+31.72%
Mr. Jonathan A. Leon
Mr. Jonathan A. Leon
Chief Financial Officer, Executive Vice President, Principal Accounting Officer
Chief Financial Officer, Executive Vice President, Principal Accounting Officer
303.59K
+28.02%
Mr. Robert J. (Bob) Henkel
Mr. Robert J. (Bob) Henkel
Independent Director
Independent Director
66.26K
+43.64%
Mr. Kenneth (Kenny) Gardner-Smith
Mr. Kenneth (Kenny) Gardner-Smith
Independent Director
Independent Director
54.92K
+52.65%
Lt. Gen. Gwendolyn M. Bingham
Lt. Gen. Gwendolyn M. Bingham
Independent Director
Independent Director
22.18K
--

āļŠāļąāļ”āļŠāđˆāļ§āļ™āļ‚āļ­āļ‡āļĢāļēāļĒāđ„āļ”āđ‰

āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 6 āļĄ.āļ„.
āļŠāļāļļāļĨāđ€āļ‡āļīāļ™: USDāļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļ­āļąāļ‡āļ„āļēāļĢāļ—āļĩāđˆ 6 āļĄ.āļ„.
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
FY2019
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Diabetes
201.37M
28.88%
Sleep therapy
185.80M
26.65%
Home respiratory therapy
107.26M
15.38%
Other
72.59M
10.41%
Ostomy
53.27M
7.64%
āļ­āļ·āđˆāļ™ āđ†
76.98M
11.04%
āļ‚āđ‰āļ­āļĄāļđāļĨāļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡āļĒāļąāļ‡āđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļāļēāļĢāđ€āļ›āļīāļ”āđ€āļœāļĒāļˆāļēāļāļ—āļēāļ‡āļšāļĢāļīāļĐāļąāļ—
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆ
āļ•āļēāļĄāļ āļđāļĄāļīāļ āļēāļ„
āļ•āļēāļĄāļ˜āļļāļĢāļāļīāļˆUSD
āļŠāļ·āđˆāļ­
āļĢāļēāļĒāđ„āļ”āđ‰
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Diabetes
201.37M
28.88%
Sleep therapy
185.80M
26.65%
Home respiratory therapy
107.26M
15.38%
Other
72.59M
10.41%
Ostomy
53.27M
7.64%
āļ­āļ·āđˆāļ™ āđ†
76.98M
11.04%

āļŠāļ–āļīāļ•āļīāļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™

āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļžāļĪāļŦāļąāļŠāļ—āļĩāđˆ 19 āļ.āļž.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āļžāļĪāļŦāļąāļŠāļ—āļĩāđˆ 19 āļ.āļž.
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Coliseum Capital Management, L.L.C.
17.14%
The Vanguard Group, Inc.
7.89%
BlackRock Institutional Trust Company, N.A.
6.44%
Charles Schwab Investment Management, Inc.
5.31%
D. E. Shaw & Co., L.P.
4.66%
āļ­āļ·āđˆāļ™ āđ†
58.57%
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Coliseum Capital Management, L.L.C.
17.14%
The Vanguard Group, Inc.
7.89%
BlackRock Institutional Trust Company, N.A.
6.44%
Charles Schwab Investment Management, Inc.
5.31%
D. E. Shaw & Co., L.P.
4.66%
āļ­āļ·āđˆāļ™ āđ†
58.57%
āļ›āļĢāļ°āđ€āļ āļ—āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™
āļŠāļąāļ”āļŠāđˆāļ§āļ™
Hedge Fund
38.32%
Investment Advisor
27.22%
Investment Advisor/Hedge Fund
21.30%
Research Firm
5.74%
Individual Investor
3.78%
Pension Fund
0.67%
Venture Capital
0.36%
Bank and Trust
0.34%
Insurance Company
0.03%
āļ­āļ·āđˆāļ™ āđ†
2.24%

āļāļēāļĢāļ–āļ·āļ­āļŦāļļāđ‰āļ™āļ‚āļ­āļ‡āļŠāļ–āļēāļšāļąāļ™


āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 3 āļĄ.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 3 āļĄ.āļ„.
āļŠāđˆāļ§āļ‡āđ€āļ§āļĨāļēāļāļēāļĢāļĢāļēāļĒāļ‡āļēāļ™
āļˆāļģāļ™āļ§āļ™āļŠāļ–āļēāļšāļąāļ™
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
2026Q1
506
75.40M
97.49%
-21.05M
2025Q4
536
75.76M
97.95%
-18.97M
2025Q3
546
76.01M
98.30%
-20.79M
2025Q2
540
78.13M
101.97%
-17.96M
2025Q1
543
77.64M
100.50%
-19.65M
2024Q4
538
79.04M
102.40%
-14.25M
2024Q3
552
79.41M
103.01%
-12.06M
2023Q4
582
79.41M
103.81%
-13.04M
2023Q2
583
76.62M
100.55%
-10.57M
2023Q1
597
75.96M
99.69%
-10.66M

āļāļīāļˆāļāļĢāļĢāļĄāļœāļđāđ‰āļ–āļ·āļ­āļŦāļļāđ‰āļ™


āļŠāļ·āđˆāļ­
āļŦāļļāđ‰āļ™āļ—āļĩāđˆāļ–āļ·āļ­āļ„āļĢāļ­āļ‡
āļŠāļąāļ”āļŠāđˆāļ§āļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™
āđ€āļ›āļĨāļĩāđˆāļĒāļ™%
āļ§āļąāļ™āļ—āļĩāđˆ
Coliseum Capital Management, L.L.C.
13.10M
16.96%
+1.54M
+13.30%
Sep 30, 2025
The Vanguard Group, Inc.
5.75M
7.43%
-2.15M
-27.27%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
4.88M
6.32%
-5.09M
-51.04%
Sep 30, 2025
Charles Schwab Investment Management, Inc.
3.21M
4.15%
+133.51K
+4.34%
Sep 30, 2025
D. E. Shaw & Co., L.P.
2.32M
3%
+890.92K
+62.34%
Sep 30, 2025
Invenomic Capital Management LP
2.75M
3.55%
+2.75M
--
Sep 30, 2025
Dimensional Fund Advisors, L.P.
3.51M
4.53%
-750.61K
-17.63%
Sep 30, 2025
Millennium Management LLC
3.26M
4.22%
+2.14M
+191.71%
Sep 30, 2025
Geode Capital Management, L.L.C.
1.46M
1.89%
-313.56K
-17.67%
Sep 30, 2025
Two Sigma Investments, LP
1.51M
1.96%
+422.35K
+38.75%
Sep 30, 2025
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ

ETF āļ—āļĩāđˆāđ€āļāļĩāđˆāļĒāļ§āļ‚āđ‰āļ­āļ‡


āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 3 āļĄ.āļ„.
āļ­āļąāļ›āđ€āļ”āļ•āđ€āļĄāļ·āđˆāļ­: āļ§āļąāļ™āđ€āļŠāļēāļĢāđŒāļ—āļĩāđˆ 3 āļĄ.āļ„.
āļŠāļ·āđˆāļ­
āļŠāļąāļ”āļŠāđˆāļ§āļ™
State Street SPDR S&P Health Care Services ETF
0.36%
Royce Quant Small-Cap Quality Value ETF
0.27%
DoubleLine Fortune 500 Equal Weight ETF
0.22%
Vanguard US Value Factor ETF
0.12%
Indexperts Quality Earnings Focused ETF
0.11%
Schwab Fundamental U.S. Small Company ETF
0.07%
First Trust Active Factor Small Cap ETF
0.04%
WisdomTree US SmallCap Fund
0.03%
Invesco Russell 2000 Dynamic Multifactor ETF
0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
āļ”āļđāđ€āļžāļīāđˆāļĄāđ€āļ•āļīāļĄ
State Street SPDR S&P Health Care Services ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.36%
Royce Quant Small-Cap Quality Value ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.27%
DoubleLine Fortune 500 Equal Weight ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.22%
Vanguard US Value Factor ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.12%
Indexperts Quality Earnings Focused ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.11%
Schwab Fundamental U.S. Small Company ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.07%
First Trust Active Factor Small Cap ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.04%
WisdomTree US SmallCap Fund
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.03%
Invesco Russell 2000 Dynamic Multifactor ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
āļŠāļąāļ”āļŠāđˆāļ§āļ™0.02%

āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ


āļĄāļĩāļāļēāļĢāļˆāđˆāļēāļĒāđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨāđ€āļ›āđ‡āļ™āļˆāļģāļ™āļ§āļ™āļĢāļ§āļĄ 0.00 USD āđƒāļ™āļŠāđˆāļ§āļ‡ 5 āļ›āļĩāļ—āļĩāđˆāļœāđˆāļēāļ™āļĄāļē
āļ§āļąāļ™āļ—āļĩāđˆ
āđ€āļ‡āļīāļ™āļ›āļąāļ™āļœāļĨ
āļ§āļąāļ™āļ—āļĩāđˆāļšāļąāļ™āļ—āļķāļ
āļ§āļąāļ™āļ—āļĩāđˆāļŠāļģāļĢāļ°āđ€āļ‡āļīāļ™
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ

āļāļēāļĢāđāļšāđˆāļ‡āļŦāļļāđ‰āļ™


āļ§āļąāļ™āļ—āļĩāđˆ
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
āļ§āļąāļ™āļ—āļĩāđˆ
āļ§āļąāļ™āļ—āļĩāđˆāđ„āļĄāđˆāđ„āļ”āđ‰āļĢāļąāļšāļŠāļīāļ—āļ˜āļīāļ›āļąāļ™āļœāļĨ
āļ›āļĢāļ°āđ€āļ āļ—
āļ­āļąāļ•āļĢāļēāļŠāđˆāļ§āļ™
āđ„āļĄāđˆāļĄāļĩāļ‚āđ‰āļ­āļĄāļđāļĨ
KeyAI
î™